Finance Watch: Dyno Therapeutics Raises $100m For Novel AAV Vectors
Roger Perlmutter Resurfaces As CEO Of Eikon, Raises $148m
Private Company Edition: Dyno’s first VC round will enable more deals for its novel AAV platform; Eikon pioneers new drug discovery technology. Also, Treeline’s early funding revealed at $211.7m; Capsida raised $140m from a VC round, AbbVie deal; and Affinia closed a $110m series B round.
